NASDAQ | TSX: ACB EDMONTON, AB , Oct. 24, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB ) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today announced today that it has scheduled a conference call to discuss the results for its second quarter 2025 on Wednesday, November 6, 2024 at 8:00 a.
m. Eastern Time | 6:00 a.m.
Mountain Time . The Company will report its financial results for the second quarter 2025 before the opening of markets that same day. Conference Call Details Miguel Martin , Chairman and Chief Executive Officer, and Simona King , Chief Financial Officer, will host the conference call and question and answer period.
This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada , Europe , Australia and South America . Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard.
Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supp.
